Eli Lilly & Co. (LLY) Tops Q2 EPS by 1c; Raises, Narrows FY11 EPS
Tweet
Share
E-mailGet Alerts LLY Hot Sheet
Price: $1,141.99 +2.36%
Revenue Growth %: +25.9%
Financial Fact:
Research and development: 1.24B
Today's EPS Names:
OCCI, VIVO, PMCB, More
Revenue Growth %: +25.9%
Financial Fact:
Research and development: 1.24B
Today's EPS Names:
OCCI, VIVO, PMCB, More
Join SI Premium – FREE
Eli Lilly & Co. (NYSE: LLY) reported Q2 EPS of $1.18, $0.01 better than the analyst estimate of $1.17. Revenue for the quarter came in at $6.25 billion versus the consensus estimate of $5.99 billion.
Eli Lilly & Co. sees FY2011 EPS of $4.25-$4.35, versus the consensus of $4.28.
Eli Lilly & Co. sees FY2011 EPS of $4.25-$4.35, versus the consensus of $4.28.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rent the Runway (RENT) Reports Q2 Loss of $0.38/sh
- IBEX Limited (IBEX) Tops Q4 EPS by 6c; offers guidance
- Macy's (M) Tops Q2 EPS by 28c, Beats on Revenue; Offers FY Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
